Adam D. George is Secretary at GW PHARMACEUTICALS PLC (GWPH). They have made 5 open-market trades across 1 company since 2019, most recently 2021-01-22.
CIK 0001754239
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GWPH | 10,000 | $2.2M |
Shares reported on the most recent Form 4, priced at the 2021-01-25 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GWPH | SELL | 2021-01-21 | 2021-01-25 | $11.69 | $733K | +50.7% | +51.5% | +54.2% |
| GWPH | SELL | 2021-01-15 | 2021-01-20 | $11.72 | $1.7M | +2.5% | +52.1% | +55.4% |
| GWPH | SELL | 2021-01-13 | 2021-01-15 | $11.03 | $13.3M | +8.6% | +56.7% | +60.6% |
| GWPH | SELL | 2019-05-07 | 2019-05-09 | $16.10 | $4.2M | +0.9% | -4.4% | -8.7% |
| GWPH | SELL | 2019-05-07 | 2019-05-09 | $16.10 | $4.2M | +0.9% | -4.4% | -8.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.